Open access
Sep 2026
KRAS Expression Complements Genomic Profiling in Identifying Therapeutic Vulnerability in Gastric Cancer.
BACKGROUND Gastric cancer (GC) remains a major therapeutic challenge. Although alterations in the RAS pathway occur in over 50% of tumors, only a limited proportion are clinically actionable. We investigated whether KRAS expression complements genomic profiling for patient stratification and therapeutic vulnerability i...
Yu-Lun Chen, Wei-Ching Chen, Ta-Sen Yeh et al.
· Biomedical Journal · 0 citations